- Home
- ELAB vs NLSP Comparison
ELAB vs NLSP Comparison
Compare ELAB & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAB
- NLSP
- Stock Information
- Founded
- ELAB 2020
- NLSP 2015
- Country
- ELAB United States
- NLSP Switzerland
- Employees
- ELAB N/A
- NLSP N/A
- Industry
- ELAB
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- ELAB
- NLSP Health Care
- Exchange
- ELAB Nasdaq
- NLSP Nasdaq
- Market Cap
- ELAB 6.6M
- NLSP 6.2M
- IPO Year
- ELAB 2023
- NLSP 2021
- Fundamental
- Price
- ELAB $1.65
- NLSP $1.95
- Analyst Decision
- ELAB
- NLSP
- Analyst Count
- ELAB 0
- NLSP 0
- Target Price
- ELAB N/A
- NLSP N/A
- AVG Volume (30 Days)
- ELAB 4.6M
- NLSP 6.1M
- Earning Date
- ELAB 03-28-2025
- NLSP 10-18-2024
- Dividend Yield
- ELAB N/A
- NLSP N/A
- EPS Growth
- ELAB N/A
- NLSP N/A
- EPS
- ELAB N/A
- NLSP N/A
- Revenue
- ELAB $2,446,161.00
- NLSP N/A
- Revenue This Year
- ELAB N/A
- NLSP N/A
- Revenue Next Year
- ELAB N/A
- NLSP N/A
- P/E Ratio
- ELAB N/A
- NLSP N/A
- Revenue Growth
- ELAB 112.17
- NLSP N/A
- 52 Week Low
- ELAB $1.60
- NLSP $1.71
- 52 Week High
- ELAB $166.00
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- ELAB 39.27
- NLSP 44.06
- Support Level
- ELAB $1.60
- NLSP $2.14
- Resistance Level
- ELAB $1.80
- NLSP $2.34
- Average True Range (ATR)
- ELAB 0.11
- NLSP 0.24
- MACD
- ELAB 0.04
- NLSP -0.00
- Stochastic Oscillator
- ELAB 15.66
- NLSP 12.07
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.